반응식
Cl[CH2:2][CH2:3][CH2:4][O:5][C:6]1[CH:11]=[CH:10][C:9]([C:12]2[CH:17]=[CH:16][C:15]([C:18]([N:20]3[CH2:24][CH2:23][CH2:22][CH2:21]3)=[O:19])=[CH:14][CH:13]=2)=[CH:8][CH:7]=1.[CH3:25][C@@H:26]1[CH2:31][CH2:30][CH2:29][C@H:28]([CH3:32])[NH:27]1>>[CH3:25][C@@H:26]1[CH2:31][CH2:30][CH2:29][C@H:28]([CH3:32])[N:27]1[CH2:2][CH2:3][CH2:4][O:5][C:6]1[CH:11]=[CH:10][C:9]([C:12]2[CH:17]=[CH:16][C:15]([C:18]([N:20]3[CH2:24][CH2:23][CH2:22][CH2:21]3)=[O:19])=[CH:14][CH:13]=2)=[CH:8][CH:7]=1참가 물질
3
실험 절차
The product from Example 11A and (2R,6S)-2,6-dimethylpiperidine were processed as described in Example 10F to provide the title compound.
출처 및 근거
- ORD 기록
- ord-5776e4694b23475da398be011cde973e
- 출처 데이터셋
- uspto-grants-2001_11
- 특허 번호
- US06316475B1
연결된 노트
불러오는 중…